AEGERION PHARMACEUTICALS, INC.

Profile

Company Names

AEGERION PHARMACEUTICALS, INC.

Addresses

1140 ROUTE 22 EAST, SUITE 304, BRIDGEWATER, NJ 08807

Phone Numbers

(908) 541-1851

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2005

State Incorporated:

DELAWARE

Total Amount Raised:

$18,314,760.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2008-09-02 
$18,314,760.00 
$19,814,760.00 
$1,500,000.00 
 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DAVID 
 
ARKOWITZ 
DIRECTOR
AEGERION PHARMACEUTICALS, INC.   |  MASCOMA CORP   |  VISTERRA, INC.   |  SPRING BANK PHARMACEUTICALS, INC.   |  YUMANITY THERAPEUTICS, INC.   |  KINETA, INC./DE   |  IBIO, INC.   |  HENDRIKLAAN 51, LLC
ALISON 
 
DE BORD 
DIRECTOR
AEGERION PHARMACEUTICALS, INC.   |  ESPERION THERAPEUTICS, INC.
JASON 
 
FISHERMAN 
DIRECTOR
AEGERION PHARMACEUTICALS, INC.   |  AMPLA PHARMACEUTICALS INC   |  PREXA PHARMACEUTICALS INC   |  TRIDENT PHARMACEUTICALS INC   |  C4 THERAPEUTICS, INC.   |  ALLOMEK THERAPEUTICS, LLC   |  ZEKANO BIO, INC.
PETER 
 
GARRAMBONE 
DIRECTOR
AEGERION PHARMACEUTICALS, INC.
ANTONIO 
M. 
GOTTO 
DIRECTOR
AEGERION PHARMACEUTICALS, INC.
ALISON 
 
KILEY 
DIRECTOR
AEGERION PHARMACEUTICALS, INC.   |  ESPERION THERAPEUTICS, INC.   |  PROLACTA BIOSCIENCE INC
WILLIAM 
H. 
LEWIS 
EXECUTIVE OFFICER
AEGERION PHARMACEUTICALS, INC.
MICHELE 
 
OLLIER 
DIRECTOR
NORMOXYS INC   |  AEGERION PHARMACEUTICALS, INC.   |  LINGUAFLEX, INC.   |  NORMOXYS, INC.   |  MINERVA NEUROSCIENCES, INC.   |  MEDICXI GROWTH I LP   |  DIASOME PHARMACEUTICALS, INC.   |  MEDICXI III LP   |  MEDICXI SECONDARY I LP   |  PALLADIO BIOSCIENCES, INC.
CHRISTINE 
 
PELLIZZARI 
EXECUTIVE OFFICER
AEGERION PHARMACEUTICALS, INC.   |  TEMPEST THERAPEUTICS, INC.   |  IMUNON, INC.
WILLIAM 
 
SASIELA 
EXECUTIVE OFFICER
AEGERION PHARMACEUTICALS, INC.
DAVID 
 
SCHEER 
DIRECTOR
AEGERION PHARMACEUTICALS, INC.   |  TENGION INC   |  PLANIT IMPACT INC.   |  DNAMX, INC.   |  REFACTOR HEALTH, INC.   |  REVELAR BIOTHERAPEUTICS, INC.   |  THYRON PHARMACEUTICALS, INC.   |  ADELA, INC.   |  THIRDLAW MOLECULAR, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2010-06-28
D/A
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2008-09-02 
2010-02-09
D/A
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2008-09-02 
2009-07-15
D/A
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2008-09-02 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#